Top Rheumatology Trends in 2025
Rheumatology is evolving at a rapid pace, and 2025 is set to introduce groundbreaking developments that will redefine how rheumatic...
The Congress of Clinical Rheumatology (CCR) is a premier annual event, bringing together healthcare professionals to stay at the forefront of rheumatology advancements since 1983. With over 25+ hours of CME/MOC credits, engaging talks from renowned speakers, and a stunning location in Destin, FL, CCR provides an unparalleled platform for learning, growth, and professional development. Whether you’re a practicing physician, fellow, nurse practitioner, or exhibitor, CCR is designed to meet your needs and help you achieve your goals. Join us for an unforgettable experience that will inspire and inform you while elevating your skills and knowledge to the next level.
Featured talks from renowned speakers from around the world, providing attendees with the latest information on treatments and advancements in the field of rheumatology.
Agenda designed to be engaging and clinically relevant, ensuring that attendees leave with a wealth of new information and knowledge.
Held at the Hilton Sandestin Golf Resort and Spa, surrounded by the award-winning Destin beaches, this event offers an unparalleled blend of education and relaxation. World-class conference facilities
Provides attendees with the opportunity to network with their peers, exchange ideas, and build professional relationships.Valuable opportunities for collaboration, learning, and support
M.D. MS
Assistant Professor in Pediatric Rheumatology and Clinical Immunology at the University of Alabama at Birmingham. Board-certified in multiple specialties, he leads the BACC YARD Program, focusing on improving transitions from pediatric to adult care for young adults with childhood-onset rheumatic diseases.
D.O.
Internationally recognized rheumatologist and immunologist at the Cleveland Clinic, where he serves as vice chair of the Department of Rheumatic and Immunologic Diseases and co-director of the Center for Vasculitis Care and Research. A prolific researcher, he has authored over 300 publications and is a leader in HIV/AIDS and hepatitis C research.
M.D.
M.D., MHS
Associate Professor at Johns Hopkins University specializing in the rheumatologic effects of cancer immunotherapy and rheumatoid arthritis. She co-chairs the Immune Related Toxicity Team, focusing on managing immune-related adverse events. She leads research on inflammatory arthritis and biomarkers in rheumatoid arthritis.
PhD
Associate Professor of Psychiatry and Anesthesiology at the University of Pennsylvania, specializing in chronic pain, opioid use disorders, and suicide risk. He directs the Pain and Chemical Dependency Research Program, advancing evidence-based treatments for pain and substance use disorders.
M.D.
Professor of Medicine in Rheumatology at the University of Colorado, specializing in autoimmune diseases with a focus on preventing rheumatoid arthritis through groundbreaking research like the StopRA trial. Recognized for his excellence in teaching and clinical practice.
M.D.
Clinical Professor of Medicine at the University of Pennsylvania and Chief of the Rheumatology Section at Pennsylvania Hospital. A Fellow of the American College of Physicians and the American College of Rheumatology, he has received prestigious awards, including the 2010 Joseph Hollander Award for excellence in rheumatology.
M.D.
Dr. Laura Hummers is an Associate Professor of Medicine, Clinical Director of the Division of Rheumatology, and Co-Director of the Johns Hopkins Scleroderma Center, specializing in scleroderma and related conditions.
M.D., Ph.D.
Dr. Kahlenberg is a leading rheumatologist and lupus researcher, recognized for her groundbreaking work on photosensitivity and cutaneous lupus, earning prestigious awards like the PECASE and ACR Henry Kunkel Young Investigator Award.
M.D.
Endowed Professor of Medicine, Rheumatology, and Aging Research at UC Davis School of Medicine, where she directs the Center for Musculoskeletal Health and NIH-funded research programs. An internationally recognized expert in osteoporosis and osteoarthritis, she has pioneered treatments for bone fragility and osteoarthritis.
M.D, MACR
Clinical Professor of Medicine and Rheumatology at LSUHSC, where he serves as Rheumatology Fellowship Program Director and Interim Section Chief. With over 40 years of experience, he has led advancements in clinical research, education, and patient care, earning the Master of Rheumatology designation from the ACR in 2017.
FRCPE FRCPGlas FRSE FMedSci CBE
Known for his pioneering work in inflammatory diseases, especially rheumatoid and psoriatic arthritis, McInnes has advanced understanding of cytokine-driven inflammation and its role in chronic diseases
M.D.
Chief of the Division of Immunology at Boston Children’s Hospital and Director of the Brigham’s Center for Adults with Pediatric Rheumatic Illness (CAPRI). A Professor of Pediatrics at Harvard Medical School, he leads the Nigrovic Laboratory.
MD, MPH
Johns Hopkins since 1986 and serves as the Director of the Hopkins Lupus Center. As a Professor of Medicine, she leads the Hopkins Lupus Cohort, a significant NIH-funded study that includes over 2,000 patients with Systemic Lupus Erythematosus
M.D.
Penn Medicine dermatologist specializing in autoimmune and rheumatologic skin diseases, including lupus and dermatomyositis. Board-certified in Dermatology, she conducts research on innovative treatments and serves as part of Penn’s Atopic Dermatitis, Autoimmune Disease, and General Dermatology Services.
M.D.
Professor of Medicine at Mayo Clinic specializing in ANCA-associated vasculitis, including granulomatosis with polyangiitis and microscopic polyangiitis. A leader in translational research and clinical trials, his work focuses on understanding disease mechanisms and developing targeted therapies to improve patient care.
The Poster Rounding Session at the Congress of Clinical Rheumatology East on May 3rd, 2025, offers presenters the opportunity to receive detailed feedback on their research or clinical cases from engaged attendees. This interactive discussion in a group setting allows for a deeper understanding of the material, promotes networking, and facilitates potential collaborations. Presenters can showcase their work to a broader audience, increasing the impact of their research or clinical cases. To submit a poster, individuals must be registered for the CCR event and follow the submission guidelines provided.
In-Depth Feedback:
Presenters receive comprehensive feedback on their research or clinical cases from a group of interested and engaged attendees.
Interactive Discussion:
The group setting fosters interactive discussions, enhancing the understanding of the research or clinical cases presented.
Networking Opportunities:
Presenters can connect with other researchers or clinicians with similar interests or expertise, facilitating networking and potential collaborations.
Broad Exposure:
The session provides an opportunity for presenters to showcase their work to a wider audience of conference attendees, increasing its visibility and reach.
Increased Impact:
Attendees actively engage with the presented material, amplifying the impact of the research or clinical cases.
On Thursday, May 1st, 2025 CCR will host a Thieves’ Market moderated by Dr. Alan Epstein, M.D. of the University of Pennsylvania. Cases are being solicited from all attendees of CCR. Submissions are due 30 days prior to the start of the event. All submissions are welcome for attendees.
Points to note:
If you are interested in submitting a case, please email your case submission to thieves@ccrheumatology.com.
Cases should be submitted as a PowerPoint file and include the following information:
Join us for this event as part of your CCR Conference Pass.
The following rules apply:
While there is an emphasis on pictorial displays of interesting physical findings or imaging studies, each case should include:
Cases that are excessively long or in formats other than PowerPoint© cannot be reviewed.
Note: Fellows need to register to present a case. A fellow may present the same case at both NYRIF and Thieves’ Market, but the format would need to be adapted accordingly.
Rheumatology is evolving at a rapid pace, and 2025 is set to introduce groundbreaking developments that will redefine how rheumatic...
The year 2024 has been marked by significant advancements in rheumatology, offering new hope for patients with conditions such as...
Does Age Matter in Psoriatic Arthritis? A Comprehensive Overview In a recent narrative review published in The Journal of Rheumatology,...
Of all of the rheumatology meetings I‘ve attended over 41 years in practice, and 2 years in fellowship, including 40 ACR annual meetings, I enjoyed and learned more at CCR” – Allen Morton, M.D.
Attending | Onsite, Online |
---|---|
Accrediation | 25+ Hours CME/MOC |
Date | May 1st – 4th, 2025 |
Venue | Hilton Sandestin Beach Golf Resort & Spa |
Location | Destin, FL. |
A&R Medical Education Group, LLC
© Copyright 2024. All Right Reserved